COVID-19

Serbia receives 1 million doses of China’s Sinopharm COVID-19 vaccine

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

Serbia receives 1 million doses of China’s Sinopharm COVID-19 vaccine

VACCINE. A plane transporting one million doses of Sinopharm's China National Biotec Group (CNBG) vaccines for the coronavirus arrives at Nikola Tesla Airport in Belgrade, Serbia, January 16, 2021.

Marko Djurica/Reuters

Serbia is the first European country to receive the Chinese vaccine for its mass inoculation program

A plane carrying one million doses of Sinopharm’s COVID-19 vaccine arrived on Saturday, January 16, in Serbia, making it the first European country to receive the Chinese vaccine for mass inoculation programs.

President Aleksandar Vucic was accompanied by Beijing’s ambassador to the Balkan country at Belgrade’s airport as containers carrying the vaccines were unloaded from an Air Serbia plane.

“I would like to thank President Xi Jinping and Chinese leadership for sending us one million doses of the vaccine,” Vucic, who has helped forge close ties with China in recent years, told reporters.

He said Serbia’s medical regulator was expected to approve the Sinopharm vaccine in the next few days, allowing vaccinations with the doses to start within a week.

More than 20,000 Serbians have so far been vaccinated since the mass inoculation began in late December, mainly elderly people in retirement homes and medical workers.

Most have received the vaccine developed by Pfizer and BioNTech or Russia’s Sputnik vaccine.

Vucic said Serbia expects to get another 250,000 doses of the Sputnik vaccine and 20,000 doses of Pfizer vaccines next week. He also said the Balkan country expects to get shipments of AstraZeneca and Moderna vaccines by June.

Neighboring Hungary expects its medical regulator to approve use of the Sinopharm vaccine for mass inoculation, after the European Commision gave its clearance for it to negotiate Sinopharm vaccine supply.

In the Western Balkan region, inoculation has started only in Serbia and Albania. Bosnia, Kosovo, Montenegro and North Macedonia have not yet received supplies of any vaccine.

China approved the shot developed by Sinopharm’s BIBP in late December, its first COVID-19 vaccine for general public use. No detailed efficacy data has been released but BIBP has said the vaccine is 79.34% effective based on interim data. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!